stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Starling Oncology, Inc. Common StockSTLN
$6.837.73%0.4902

Starling Oncology, Inc. Common Stock (STLN)

Date: 2026-11-04 16:00O: 6.44H: 6.98L: 6.41C: 6.98Vol: 898.8k
Starling Oncology, Inc. Common Stock stock is traded at $6.83, with a volume of 469,221. It is up +7.73% in the last 24 hours and up +7.56% over the past month.
Previous Close:
$6.34
Open:
$6.44
24h Volume:
469,221
Relative Volume:
0.37
Market Cap:
$696.11M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.86%
1M Performance:
+7.56%
6M Performance:
0.00%
1Y Performance:
0.00%
1-Day Range:
$6.41$6.84
1-Week Range:
$6.19$6.85
52-Week Range:
$4.85$7.13

Starling Oncology, Inc. Common Stock Stock (STLN) Company Profile

Name
Starling Oncology, Inc. Common Stock
Phone
-
Address
USA
Employee
641
X
-
Next Earnings Date
2026-11-05
Latest SEC Filings
SEC
STLN's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Starling Oncology, Inc. Common Stock Stock (STLN) Upgrades & Downgrades

DateActionAnalystRating Change
Jul-06-26InitiatedLake StreetBuy
Nov-25-25InitiatedNeedhamBuy
Jul-23-25InitiatedNoble Capital MarketsOutperform
Jul-16-25InitiatedB. Riley SecuritiesBuy

Starling Oncology, Inc. Common Stock Stock (STLN) Financials Data

PeriodTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Period End Date2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)502.73393.41324.24252.48203.00
Operating income USD (M)-36.08-60.12-77.02-81.95-45.86
Income before tax USD (M)-60.74-64.66-83.10-0.09-11.60
Income tax expense USD (M)-0.130.00-0.04-0.24-0.67
Net income USD (M)-60.61-64.66-83.070.15-10.93
Basic EPS USD/shares-0.54-0.71-0.920.00-0.16
Diluted EPS USD/shares-0.54-0.71-0.92-0.21-0.16
Basic weighted shares shares (M)92.3975.0473.7572.7966.23
Diluted weighted shares shares (M)92.3975.0473.7580.6166.23
Selling, general and administrative USD (M)105.57107.83113.85119.6983.37

Starling Oncology, Inc. Common Stock Stock (STLN) Insider Trading

  • BRADFORD HIVELYAug 21 '26
    Director
    Transaction
    Proposed Sale
    Cost
    $6.54
    #Shares
    298,853
    Value ($)
    1,954,499
    #Shares Total
    0
  • Hively BradAug 21 '26
    Director
    Transaction
    Sale
    Cost
    $6.51
    #Shares
    298,853
    Value ($)
    1,946,310
    #Shares Total
    411,976
  • Chernett JoreyAug 14 '26
    10% Owner
    Transaction
    Buy
    Cost
    $6.54
    #Shares
    12,000
    Value ($)
    78,480
    #Shares Total
    10,660,858
  • Chernett JoreyJul 21 '26
    10% Owner
    Transaction
    Buy
    Cost
    $5.27
    #Shares
    18,000
    Value ($)
    94,860
    #Shares Total
    10,648,858
  • Podnos YaleJul 14 '26
    Chief Medical Officer
    Transaction
    Sale
    Cost
    $6.41
    #Shares
    23,452
    Value ($)
    150,340
    #Shares Total
    259,527
  • YALE PODNOSJul 14 '26
    Officer
    Transaction
    Proposed Sale
    Cost
    $6.25
    #Shares
    23,452
    Value ($)
    146,575
    #Shares Total
    0
  • Podnos YaleJul 14 '26
    Chief Medical Officer
    Transaction
    Option Exercise
    Cost
    $1.90
    #Shares
    23,452
    Value ($)
    44,567
    #Shares Total
    277,501
  • Chernett JoreyJul 10 '26
    10% Owner
    Transaction
    Buy
    Cost
    $5.85
    #Shares
    15,000
    Value ($)
    87,750
    #Shares Total
    10,630,858
  • Chernett JoreyJun 23 '26
    10% Owner
    Transaction
    Buy
    Cost
    $5.02
    #Shares
    18,000
    Value ($)
    90,360
    #Shares Total
    10,615,858
  • YALE PODNOSJun 08 '26
    Officer
    Transaction
    Proposed Sale
    Cost
    $4.87
    #Shares
    23,451
    Value ($)
    114,206
    #Shares Total
    0
Insider TradingRelationshipDateTransactionCost#SharesValue ($)#Shares Total
BRADFORD HIVELYDirectorAug 21 '26Proposed Sale$6.54298,8531,954,4990
Hively BradDirectorAug 21 '26Sale$6.51298,8531,946,310411,976
Chernett Jorey10% OwnerAug 14 '26Buy$6.5412,00078,48010,660,858
Chernett Jorey10% OwnerJul 21 '26Buy$5.2718,00094,86010,648,858
Podnos YaleChief Medical OfficerJul 14 '26Sale$6.4123,452150,340259,527
YALE PODNOSOfficerJul 14 '26Proposed Sale$6.2523,452146,5750
Podnos YaleChief Medical OfficerJul 14 '26Option Exercise$1.9023,45244,567277,501
Chernett Jorey10% OwnerJul 10 '26Buy$5.8515,00087,75010,630,858
Chernett Jorey10% OwnerJun 23 '26Buy$5.0218,00090,36010,615,858
YALE PODNOSOfficerJun 08 '26Proposed Sale$4.8723,451114,2060

Starling Oncology, Inc. Common Stock Stock (STLN) Latest News

Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 19, 2026
Oct 19, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 10, 2026
Oct 10, 2026
Oct 07, 2026
Oct 07, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 20, 2026
Sep 20, 2026
Sep 20, 2026
Sep 20, 2026
Sep 14, 2026
Sep 14, 2026
Sep 08, 2026
Sep 08, 2026
Aug 27, 2026
Aug 27, 2026
Aug 24, 2026
Aug 24, 2026
Aug 21, 2026
Aug 21, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 14, 2026
Aug 14, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 08, 2026
Aug 08, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Jul 13, 2026
Jul 13, 2026
Jul 06, 2026
Jul 06, 2026
Jun 24, 2026
Jun 24, 2026
Mar 12, 2026
Mar 12, 2026
Nov 14, 2025
Nov 14, 2025
Oct 21, 2025
Oct 21, 2025

Similar to STLN